遺伝子編集技術市場：提供、技術、用途、エンドユーザー別-2025-2030年の世界予測

遺伝子編集技術市場は2023年に51億2,000万米ドルと評価され、2024年には57億3,000万米ドルに達すると予測され、CAGR 12.57％で成長し、2030年には117億4,000万米ドルになると予測されています。

遺伝子編集技術は、生物のDNAに標的を定めた改変を可能にする様々な分子ツールを包含し、様々な領域で変革の可能性を提供します。これらの技術の必要性は、遺伝子疾患への対処、農作物の改良、バイオテクノロジー・プロセスの強化におけるその精度と効率性にあります。その応用範囲はヘルスケア、農業、工業バイオテクノロジーに及ぶ。ヘルスケアでは、遺伝子編集は遺伝性疾患の治療、個別化医療の開発、再生医療の進展に有望です。農業分野では、これらの技術により、収量の向上、病害虫への抵抗性、悪条件への耐性を備えた作物の開発が促進されます。一方、産業応用としては、バイオ燃料生産や発酵プロセスがあります。世界の食糧安全保障の課題と並んで、高度な治療ソリューションが必要とされる遺伝性疾患や慢性疾患の蔓延が、作物改変の進歩を後押ししていることも、重要な促進要因となっています。合成生物学分野の急成長は遺伝子編集ツールの需要をさらに押し上げます。CRISPR技術とその派生技術を活用し、研究への継続的な投資と提携によって、治療的解決策と作物工学の限界を押し広げる機会があります。しかしながら、倫理的な懸念、規制上のハードル、予期せぬ遺伝的変化をもたらす可能性のある標的外影響などの制約があり、これは依然として大きな課題です。透明性のある利害関係者とのコミュニケーションと強固な倫理的枠組みを通じて、一般市民と規制当局の不安に対処することが、市場拡大には不可欠です。技術革新は、遺伝子編集ツールの精度と特異性の改良、治療応用のための送達システムの開発、より良いゲノムデータ解析のためのバイオインフォマティクス・インフラストラクチャの拡充に焦点を当てるべきです。市場のダイナミクスは、急速な進歩を特徴とするが、潜在的な生物政治的論争のため注意が必要です。これらの技術は急成長中の研究・商業分野であり、持続的成長には戦略的パートナーシップ、継続的な研究開発投資、倫理基準の遵守が不可欠です。

市場力学：急速に進化する遺伝子編集技術市場の主要市場インサイトを公開

遺伝子編集技術市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の遺伝性疾患の有病率の上昇
  • 遺伝子編集の研究開発への投資の増加
  • CRISPRベースのツールの大幅な改良
• 市場抑制要因
  • 遺伝子編集技術の開発コストの高さ
• 市場機会
  • 遺伝子編集技術の技術的進歩
  • 個別化医療への傾斜
• 市場の課題
  • 倫理的懸念と厳しい規制の枠組み

ポーターのファイブフォース：遺伝子編集技術市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：遺伝子編集技術市場における外部からの影響の把握

外部マクロ環境要因は、遺伝子編集技術市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析遺伝子編集技術市場における競合情勢の把握

遺伝子編集技術市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス遺伝子編集技術市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、遺伝子編集技術市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨遺伝子編集技術市場における成功への道筋を描く

遺伝子編集技術市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で遺伝性疾患の罹患率が上昇
    • 遺伝子編集の研究開発への投資増加
    • CRISPRベースのツールの大幅な改善
  • 抑制要因
    • 遺伝子編集技術の開発コストが高い
  • 機会
    • 遺伝子編集技術における技術的進歩
    • 個別化医療へのアプローチへの傾向
  • 課題
    • 倫理的な懸念と厳格な規制枠組み
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 遺伝子編集技術市場：提供別

• 試薬・消耗品
• サービス
• ソフトウェアとシステム

第7章 遺伝子編集技術市場：技術別

• アンチセンス
• クリスパー
• タレン
• ジンクフィンガーヌクレアーゼ（ZFN）

第8章 遺伝子編集技術市場：用途別

• 動物遺伝子工学
• 細胞株エンジニアリング
• 遺伝子工学
• 植物遺伝子工学

第9章 遺伝子編集技術市場：エンドユーザー別

• 学術機関および政府調査機関
• バイオテクノロジーおよび製薬会社
• 契約調査機関

第10章 南北アメリカの遺伝子編集技術市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の遺伝子編集技術市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの遺伝子編集技術市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Agilent Technologies, Inc.
• AMS Biotechnology Ltd.
• Beam Therapeutics Inc.
• Caribou Biosciences, Inc.
• Cellectis SA
• Creative Biogene
• CRISPR Therapeutics AG
• Editas Medicine, Inc.
• GenScript Biotech Corporation
• Horizon Discovery Ltd.
• Inscripta, Inc.
• Integrated DNA Technologies, Inc.
• Intellia Therapeutics, Inc.
• Lonza Group Ltd.
• Mammoth Biosciences, Inc.
• Merck Group
• New England Biolabs, Inc.
• OriGene Technologies, Inc.
• Precision BioSciences, Inc.
• Sangamo Therapeutics, Inc.
• Synthego Corporation
• Takara Bio Inc.
• Tecan Trading AG
• Thermo Fisher Scientific, Inc.

LIST OF FIGURES

• FIGURE 1. GENE EDITING TECHNOLOGIES MARKET RESEARCH PROCESS
• FIGURE 2. GENE EDITING TECHNOLOGIES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. GENE EDITING TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. GENE EDITING TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. GENE EDITING TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. GENE EDITING TECHNOLOGIES MARKET DYNAMICS
• TABLE 7. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ANTISENSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TALEN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ZINC FINGER NUCLEASES (ZFN), BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ANIMAL GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY PLANT GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 38. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 39. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. CHINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 61. CHINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 62. CHINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. CHINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. INDIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 65. INDIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. INDIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. INDIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 133. ITALY GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 134. ITALY GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 135. ITALY GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. ITALY GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 149. POLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 150. POLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 151. POLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. POLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 153. QATAR GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 154. QATAR GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 155. QATAR GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. QATAR GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 193. GENE EDITING TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 194. GENE EDITING TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

The Gene Editing Technologies Market was valued at USD 5.12 billion in 2023, expected to reach USD 5.73 billion in 2024, and is projected to grow at a CAGR of 12.57%, to USD 11.74 billion by 2030.

Gene editing technologies encompass a range of molecular tools that enable targeted modifications to the DNA of organisms, offering transformative potential across various domains. The necessity of these technologies lies in their precision and efficiency in addressing genetic disorders, improving agricultural crops, and enhancing biotechnological processes. Applications span healthcare, agriculture, and industrial biotechnology. In healthcare, gene editing holds promise for curing genetic diseases, developing personalized medicine, and advancing regenerative medicine. In agriculture, these technologies facilitate the development of crops with improved yield, resistance to pests and diseases, and tolerance to adverse conditions. Meanwhile, industrial applications include biofuel production and fermentation processes. A critical growth driver is the increasing prevalence of genetic and chronic diseases necessitating advanced therapeutic solutions, alongside the global food security challenge propelling advancements in crop modification. The burgeoning field of synthetic biology further boosts demand for gene editing tools. Opportunities lie in leveraging CRISPR technology and its derivatives to push boundaries in therapeutic solutions and crop engineering, with continuous investments and partnerships in research. However, limitations include ethical concerns, regulatory hurdles, and potential off-target effects that may lead to unforeseen genetic changes, which remain a significant challenge. Addressing public and regulatory apprehensions through transparent stakeholder communication and robust ethical frameworks is vital for market expansion. Innovation should focus on refining precision and specificity of gene-editing tools, developing delivery systems for therapeutic applications, and expanding the bioinformatics infrastructure for better genomic data analysis. Market dynamics are characterized by rapid advancements but with caution due to potential biopolitical controversies. These technologies represent a burgeoning area of research and commercial interest, where strategic partnerships, continuous R&D investment, and adherence to ethical standards will be critical for sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gene Editing Technologies Market

The Gene Editing Technologies Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of genetic disorders worldwide
  • Increasing investments for R&D in gene editing
  • Significant improvements in CRISPR-based tools
• Market Restraints
  • High cost of development of gene editing technologies
• Market Opportunities
  • Technological advancements in gene editing technologies
  • Inclination toward personalized medicine approach
• Market Challenges
  • Ethical concerns and stringent regulatory framework

Porter's Five Forces: A Strategic Tool for Navigating the Gene Editing Technologies Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gene Editing Technologies Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gene Editing Technologies Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gene Editing Technologies Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gene Editing Technologies Market

A detailed market share analysis in the Gene Editing Technologies Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gene Editing Technologies Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gene Editing Technologies Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gene Editing Technologies Market

A strategic analysis of the Gene Editing Technologies Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gene Editing Technologies Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., AMS Biotechnology Ltd., Beam Therapeutics Inc., Caribou Biosciences, Inc., Cellectis SA, Creative Biogene, CRISPR Therapeutics AG, Editas Medicine, Inc., GenScript Biotech Corporation, Horizon Discovery Ltd., Inscripta, Inc., Integrated DNA Technologies, Inc., Intellia Therapeutics, Inc., Lonza Group Ltd., Mammoth Biosciences, Inc., Merck Group, New England Biolabs, Inc., OriGene Technologies, Inc., Precision BioSciences, Inc., Sangamo Therapeutics, Inc., Synthego Corporation, Takara Bio Inc., Tecan Trading AG, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Gene Editing Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Offering, market is studied across Reagents & Consumables, Services, and Software & Systems.
• Based on Technology, market is studied across Antisense, CRISPR, Talen, and Zinc Finger Nucleases (ZFN).
• Based on Application, market is studied across Animal Genetic Engineering, Cell Line Engineering, Genetic Engineering, and Plant Genetic Engineering.
• Based on End User, market is studied across Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of genetic disorders worldwide
    • 5.1.1.2. Increasing investments for R&D in gene editing
    • 5.1.1.3. Significant improvements in CRISPR-based tools
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of development of gene editing technologies
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in gene editing technologies
    • 5.1.3.2. Inclination toward personalized medicine approach
  • 5.1.4. Challenges
    • 5.1.4.1. Ethical concerns and stringent regulatory framework
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Gene Editing Technologies Market, by Offering

• 6.1. Introduction
• 6.2. Reagents & Consumables
• 6.3. Services
• 6.4. Software & Systems

7. Gene Editing Technologies Market, by Technology

• 7.1. Introduction
• 7.2. Antisense
• 7.3. CRISPR
• 7.4. Talen
• 7.5. Zinc Finger Nucleases (ZFN)

8. Gene Editing Technologies Market, by Application

• 8.1. Introduction
• 8.2. Animal Genetic Engineering
• 8.3. Cell Line Engineering
• 8.4. Genetic Engineering
• 8.5. Plant Genetic Engineering

9. Gene Editing Technologies Market, by End User

• 9.1. Introduction
• 9.2. Academic & Government Research Institutes
• 9.3. Biotechnology & Pharmaceutical Companies
• 9.4. Contract Research Organizations

10. Americas Gene Editing Technologies Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Gene Editing Technologies Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Gene Editing Technologies Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. AMS Biotechnology Ltd.
• 3. Beam Therapeutics Inc.
• 4. Caribou Biosciences, Inc.
• 5. Cellectis SA
• 6. Creative Biogene
• 7. CRISPR Therapeutics AG
• 8. Editas Medicine, Inc.
• 9. GenScript Biotech Corporation
• 10. Horizon Discovery Ltd.
• 11. Inscripta, Inc.
• 12. Integrated DNA Technologies, Inc.
• 13. Intellia Therapeutics, Inc.
• 14. Lonza Group Ltd.
• 15. Mammoth Biosciences, Inc.
• 16. Merck Group
• 17. New England Biolabs, Inc.
• 18. OriGene Technologies, Inc.
• 19. Precision BioSciences, Inc.
• 20. Sangamo Therapeutics, Inc.
• 21. Synthego Corporation
• 22. Takara Bio Inc.
• 23. Tecan Trading AG
• 24. Thermo Fisher Scientific, Inc.